Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization
Micro Cap Biotechnology Stocks at a Glance
Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.
There are 294 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $17.7B.
The largest by market cap are Clinuvel Pharmaceuticals (CUVL) at $245M, Lexeo Therapeutics (LXEO) at $242M and Allogene Therapeutics (ALLO) at $241M.
Among institutional investors, Faeth Therapeutics (FTH) drew the most net new fund positions in Q3 2026: 41 funds opened new positions, taking total fund holders up 34 (76%) quarter-over-quarter.
- Combined market cap: $17.7B across 294 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Clinuvel Pharmaceuticals (CUVL), $245M market cap.
- Most net new fund positions in Q3 2026: Faeth Therapeutics (FTH), +34 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.